elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26830699-03F64668-F00C-454C-9D1C-5EA6A2170ACC
Q26830699-03F64668-F00C-454C-9D1C-5EA6A2170ACC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26830699-03F64668-F00C-454C-9D1C-5EA6A2170ACC
Site-specific functionalization of proteins and their applications to therapeutic antibodies
P2860
Q26830699-03F64668-F00C-454C-9D1C-5EA6A2170ACC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26830699-03F64668-F00C-454C-9D1C-5EA6A2170ACC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
076caba079123c034cc6d810ac0d33af0e0c8fd0
P2860
Bispecific antibodies for cancer therapy: the light at the end of the tunnel?